Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
NCT ID: NCT06956326
Last Updated: 2025-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
64 participants
INTERVENTIONAL
2025-05-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis
NCT06303024
Exercise in Severely Disabled Patients With MS
NCT01752660
Reinventing Yourself With Multiple Sclerosis (MS)
NCT05195320
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
NCT04749667
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive rehab
10 weeks of community-based physical therapy. Participants will receive two weekly supervised physical therapy session (45-60 minutes).
The content of this exercise program and the specific exercises and exercise methods will be planned in collaboration between MS specialists from the Danish MS hospitals, the local physical therapist, and the participant.
Intensive rehab
Frequent moderate-to-high intensity physical therapy, provided by local physiotherapists.
Usual care
10 weeks of usual care physiotherapy, normally comprised of municipal rehabilitation as well as self-administered behavior.
Usual care
Usual care physiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive rehab
Frequent moderate-to-high intensity physical therapy, provided by local physiotherapists.
Usual care
Usual care physiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed motor relapse (within the past 6 months) by a neurologist, with disability/ functional interference characterized by change in pyramidal, and/or cerebellar functional scores of 2 or higher
* completed steroid or other acute relapse treatment, if prescribed
* age over 18 years
Exclusion Criteria
* medical conditions or substantial cognitive impairments that hinder participation in the study (e.g. inability to perform or understand the intensive rehabilitation)
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lars Hvid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Hvid
Senior Researcher, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Danish MS Hospitals
Haslev, , Denmark
The Danish MS Hospitals
Ry, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS_Early_Rehab
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.